Evidence map›Paper›PMID 25548275›Full record

ArticleThe Journal of biological chemistry2015

Induction and activation of latent transforming growth factor-β1 are carried out by two distinct domains of pregnancy-specific glycoprotein 1 (PSG1).

Angela Ballesteros, Margaret M Mentink-Kane, James Warren, Gerardo G Kaplan, Gabriela S Dveksler

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Angela BallesterosFrom the Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892 and.
Margaret M Mentink-Kanethe Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.
James Warrenthe Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.
Gerardo G KaplanFrom the Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892 and.
Gabriela S Dvekslerthe Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 gabriela.dveksler@usuhs.edu.
Uniformed Services University of the Health Sciences · USCenter for Biologics Evaluation and Research · US

Funding

Pregnancy specific glycoprotein 1 activates transforming growth factor betaR21AI101979 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI DVEKSLER, GABRIELA S · 2012 to 2013
$399k
NIAID NIH HHS R21 AI101979NIAID NIH HHS R21AI101979
6 · The paper itself

Abstract

Pregnancy-specific glycoproteins (PSGs) are a family of Ig-like proteins secreted by specialized placental cells. The PSG1 structure is composed of a single Ig variable region-like N-terminal domain and three Ig constant region-like domains termed A1, A2, and B2. Members of the human and murine PSG family have been shown to induce anti-inflammatory cytokines from monocytes and macrophages and to stimulate angiogenesis. We recently showed that recombinant forms of PSG1 (PSG1-Fc and PSG1-His) and PSG1 purified from the serum of pregnant women are associated with the immunoregulatory cytokine TGF-β1 and activated latent TGF-β1. Here, we sought to examine the requirement of specific PSG1 domains in the activation of latent TGF-β1. Plasmon surface resonance studies showed that PSG1 directly bound to the small latent complex and to the latency-associated peptide of TGF-β1 and that this binding was mediated through the B2 domain. Furthermore, the B2 domain alone was sufficient for activating the small latent complex. In separate experiments, we found that the PSG1-mediated induction of TGF-β1 secretion in macrophages was dependent on the N-terminal domain. Mutagenesis analysis revealed that four amino acids (LYHY) of the CC' loop of the N-terminal domain were required for induction of latent TGF-β1 secretion. Together, our results show that two distinct domains of PSG1 are involved in the regulation of TGF-β1 and provide a mechanistic framework for how PSGs modulate the immunoregulatory environment at the maternal-fetal interface for successful pregnancy outcome.

Indexed as

AnimalsBlotting, WesternCells, CulturedCytokinesFemaleHumansImmunoenzyme TechniquesMacrophagesMiceMonocytesPlacentaPregnancyPregnancy-Specific beta 1-GlycoproteinsProtein ConformationProtein Structure, TertiaryReal-Time Polymerase Chain ReactionCytokinesPregnancy-Specific beta 1-GlycoproteinsRNA, MessengerTransforming Growth Factor beta1Heparan SulfateLatency-associated PeptideLatent TGF-β1MacrophagePlacentaPregnancySurface Plasmon Resonance (SPR)

Identifiers

PMID25548275
PMCPMC4326847
OpenAlexW2021884639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.